CAS 111076-33-6

Quinoxalino[2,3-b]phenazine,5,14-dihydro-

Description:

Quinoxalino[2,3-b]phenazine,5,14-dihydro- is a heterocyclic compound characterized by its fused ring structure, which includes both quinoxaline and phenazine moieties. This compound typically exhibits properties associated with aromatic systems, such as stability and potential for electron delocalization. It may display fluorescence, making it of interest in various applications, including organic electronics and photonic devices. The presence of nitrogen atoms in its structure can influence its reactivity and solubility, often making it more polar than purely hydrocarbon-based compounds. Additionally, the dihydro form indicates that it has two hydrogen atoms added to the structure, which may affect its electronic properties and reactivity compared to its fully aromatic counterparts. Quinoxalino[2,3-b]phenazine derivatives are often studied for their biological activities, including potential antimicrobial and anticancer properties, due to their ability to interact with biological molecules. Overall, this compound represents a fascinating area of study within organic and medicinal chemistry, with implications for material science and pharmacology.

Formula: C₁₈H₁₂N₄

Synonyms:

• 5,14-Dihydro-5,7,12,14-tetraazapentacene
• Fluorindine

Fluorindine

Controlled Product

CAS: 111076-33-6

Formula: C₁₈H₁₂N₄

Color and Shape: Neat

Molecular weight: 284.31

Ref: TR-F485800

Fluorindine

CAS: 111076-33-6

Fluorindine is a medicinal compound that has shown promise in inhibiting the growth of cancer cells. It works by targeting specific kinases involved in cell cycle regulation and inducing apoptosis, or programmed cell death, in tumor cells. Fluorindine has been tested on human and Chinese hamster cells and has shown potent anticancer activity. It also acts as an inhibitor of nintedanib, a protein kinase inhibitor that is used to treat certain types of cancer. In addition, Fluorindine has been found to have potential for use as an anticancer drug due to its ability to inhibit the activity of apomorphine, a protein involved in cancer cell growth. Overall, Fluorindine has promising potential as a novel therapeutic agent for the treatment of cancer.

Formula: C₅H₄FIn

Purity: Min. 95%

Molecular weight: 197.9 g/mol

Ref: 3D-LEA07633